SEC Filings

SEC Filings

Document Date	Description	Filing Group	View
Aug 22, 2019	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-19-008280.pdf 0001558370-19-008280.rtf 0001558370-19-008280.xls View HTML
Aug 21, 2019	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-19-008273.pdf 0001558370-19-008273.rtf 0001558370-19-008273.xls View HTML
Jun 30, 2019	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-19-008146.pdf 0001558370-19-008146.rtf 0001558370-19-008146.xls EX-101.INS View HTML
Jul 23, 2019	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-19-006206.pdf 0001558370-19-006206.rtf 0001558370-19-006206.xls View HTML
Jul 22, 2019	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-19-006177.pdf 0001558370-19-006177.rtf 0001558370-19-006177.xls View HTML
Jul 19, 2019	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	Registration Statements	0001047469-19-004269.pdf 0001047469-19-004269.rtf 0001047469-19-004269.xls View HTML
Jul 17, 2019	Securities offered to employees pursuant to employee benefit plans	Registration Statements	0000947871-19-000524.pdf 0000947871-19-000524.rtf 0000947871-19-000524.xls View HTML
Jul 17, 2019	Registration of up to an additional 20% of securities for an offering filed on an F-1	Registration Statements	0001047469-19-004244.pdf 0001047469-19-004244.rtf 0001047469-19-004244.xls View HTML
Jul 17, 2019	EFFECT	Other	9999999995-19-001624.pdf 9999999995-19-001624.rtf View HTML
Jul 17, 2019	F-6EF	Other	0000950127-19-000062.pdf 0000950127-19-000062.rtf 0000950127-19-000062.xls View HTML

Data provided by Kaleidoscope.

Who we are

Read about Genmab's purpose, core values and key accomplishments

Learn more
Turning insights into medicine

See the results of innovation that is rooted in science

Explore the pipeline
Innovation for the future

We are developing next-generation technologies

See our technologies

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.

You are now leaving Genmab.com and will be directed to a page intended for U.S. audiences only. Click Continue to confirm you are located in the U.S.